C
China NT Pharma Group Company Ltd
HKEX:1011
China NT Pharma Group Company Ltd
HKEX:1011
Price:
0.72
HKD
-1.37%
Market Closed
Market Cap:
HK$485.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China NT Pharma Group Company Ltd
HKEX:1011
|
CN |
|
H
|
Herbs Generation Group Holdings Ltd
HKEX:2593
|
HK |
|
Nabtesco Corp
TSE:6268
|
JP |
|
G
|
Gemini Space Station Inc
NASDAQ:GEMI
|
US |
|
K
|
Konya Cimento Sanayii AS
IST:KONYA.E
|
TR |
Multiples-Based Value
The Multiples-Based Value of one China NT Pharma Group Company Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.72 HKD, China NT Pharma Group Company Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China NT Pharma Group Company Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
China NT Pharma Group Company Ltd Competitors
China NT Pharma Group Company Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China NT Pharma Group Company Ltd
HKEX:1011
|
485.5m HKD | 22.9 | -6 | -16.7 | -16.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
